PTK2 and glioblastoma: Y15 has previously been shown to decrease cell viability and clonogenicity of various carcinomas and to increase detachment, cause apoptosis, and inhibit invasion of glioblastoma cells through the inhibition of FAK phosphorylation (Golubovskaya et al., 2013; Zhang et al., 2016).